Abstract. The aim of the present study was to investigate the role of microRNA (miR)-21 in regulating collagen I and Smad7 expression in activated rat hepatic stellate cells (HSCs). Rat HSCs were isolated by single-step density gradient centrifugation with Nycodenz. Cellular content of miR-21, SMAD7, α-smooth muscle actin (α-SMA), collagen type I alpha 1 (COLLA1) and COLL alpha 2 (A2) mRNA was examined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and cellular content of Smad7 and α-SMA protein was detected by western blotting. Binding of miR-21 to the 3'-untranslated region (UTR) of Smad7 was verified by dual-luciferase assay. The authors observed that, in activated HSCs, expression of miR-21 was significantly increased in a time-dependent manner, while expression of Smad7 mRNA and protein was significantly reduced. In addition, miR-21 mimics significantly enhanced cellular α-SMA mRNA and protein content, while miR-21 inhibitor significantly reduced α-SMA mRNA and protein levels. Similarly, cellular content of COLLA1 and COLLA2 mRNA was significantly elevated by miR-21 mimics, but reduced by miR-21 inhibitor, in activated HSCs. Moreover, cellular content of Smad7 mRNA and protein was significantly reduced by miR-21 mimics, but significantly increased by miR-21 inhibitor. Furthermore, miR-21 mimics activated firefly luciferase in HEK293 cells transfected with the wild type 3'-UTR of Smad7. miR-21 regulates expression of α-SMA and collagen I in activated rat HSCs by directly targeting Smad7.
Introduction
The primary cause of liver fibrosis is chronic inflammation, which is characterized by excessive scarring (1) . In response to chronic liver injury and inflammation, fibrogenic precursor cells, hepatic stellate cells (HSCs), transdifferentiate into fibrogenic myofibroblasts (1, 2) . An array of cytokines contribute to transdifferentiation of HSCs, of which transforming growth factor (TGF)-β1 is an important profibrogenic cytokine that accelerates fibrosis by triggering proliferation and differentiation of HSCs into myofibroblasts, a process termed HSC activation (3, 4) . Activation of HSCs by TGF-β is usually accompanied by increased synthesis, and decreased degradation, of ECM proteins, in particular collagen I and II (5) . Smad7 is an important feedback inhibitor of TGF-β signaling (6) . TGF-β induces phosphorylation of Smad2/3 and Smad4, which in turn upregulates Smad7 transcription (7) . Excess Smad7 forms a stable complex with the activated type I receptor, thereby preventing Smad phosphorylation, and subsequent downstream events (8) . Smad7 is a potential master transcriptional repressor of HSC transdifferentiation. Smad7 overexpression in the liver has been demonstrated to inhibit phosphorylation of Smad2/3 and expression of collagen I, thus protecting against HSC activation and liver fibrosis (9) . Conversely, epigenetic repression of Smad7 by DNA methylation promotes HSC activation and liver fibrosis in rats (3) .
MicroRNAs (miRs) are endogenous, non-coding single-stranded RNAs of 18 to 24 nucleotides that negatively regulate gene expression by binding the 3'-untranslated region (UTR) of target mRNAs (10) . Dysregulation of miRs is associated with a variety of diseases, including cancer and liver fibrosis (1, 11) . miR-21 is ubiquitously expressed, and was identified as being highly upregulated in most types of cancer (12) . Elevated levels of miR-21 were previously reported to be associated with initiation of myocardial, renal and pulmonary fibrosis (13, 14) . miR-21 expression is stimulated during fibrosis by profibrogenic TGF-β. TGF-β induces phosphorylation of Smad2 and 3 (R-Smads), which can interact with the p68 RNA helicase of the Drosha/PDCD4 microprocessor complex, suppressing the transformation of pri-miR-21 into the precursor pre-miR-21 (15) . In response to TGF-β stimulation, transcriptional upregulation of miR-21 is reported to be mediated by activation of Smad-3 rather than Smad-2 (16). Moreover, different patterns of miRNA expression were observed in chronic liver diseases of various etiologies. Overexpression of miR-21 was recently reported to promote activation of human hepatic stellate LX-2 cells, while downregulation of miR-21 blocked activation of these cells, suggesting that miR-21 may also have a direct fibrogenic effect in the liver (17) . Although high levels of miR-21 expression are associated with the onset of liver fibrosis (18, 19) , the effect of miR-21 on liver fibrosis is remains elusive.
Interestingly, miR-21 was recently hypothesized to regulate synthesis of TGF-β inhibitory Smad7 protein (20) . However, a direct interaction between miR-21 and Smad7 has rarely been reported in fibrogenic conditions. Smad7 has been reported to inhibit type I collagen expression, but evidence that the expression of collagens is regulated by miR-21 in HSCs is still lacking. In the present study, therefore, the authors investigated the effect of miR-21 on the expression of type I collagen mRNA and protein in rat HSCs, and further investigated the role of Smad7 in this regulation.
Materials and methods

Animals and reagents.
Male Sprague-Dawley (one year-old) rats (weight, 500-600 g) were provided by the Experimental Animal Center of Wenzhou Medical University (Rui'an, China). All rats were housed at 21±1˚C, with 55±15% humidity and a dark/light cycle of 12/12 h, and provided access to food and water ad libitum. The experimental protocols were reviewed and approved by the Ethics Committee of Wenzhou Medical University (Rui'an, China).
Fetal Isolation and culture of HSCs. HSCs were isolated as previously described, with minor modifications (21) . Briefly, the rats were anesthetized by intraperitoneal injection of 54 mg/kg sodium pentobarbital. A small piece (100-200 mg) of liver tissue was excised using scissors and digested in 1 ml digestion solution containing 0.5 mg/ml pronase E, 0.6 mg/ml collagenase and 0.1 mg/ml deoxyribonuclease (from the bovine pancreas, Grade II, Boehringer Ingelheim GmbH, Ingelheim, Germany) dissolved in Gey's balanced salt solution (GBSS) for 45 min at 37˚C. The cell suspension was centrifuged at 450 x g for 6 min at 4˚C. The cell pellet was resuspended in 15 ml GBSS containing 3 g/l bovine serum albumin and mixed with 12.5 ml 28.7% (w/v) of Nycodenz (Nycomed, Zurich, Switzerland) in GBSS without NaCl. The mixture was centrifuged at 1,400 x g for 20 min at 4˚C. Then the white, diffuse band overlaying the Nycodenz cushion was gently aspirated, diluted in 40 ml GBSS and centrifuged at 450 x g for 7 min at 4˚C. The cell pellet was suspended and cultured in DMEM supplemented with L-glutamine (4 mmol/l), penicillin (100 IU/ml), streptomycin (100 µg/ml) and 10% FBS in a humidified atmosphere of 5% CO 2 /95% air at 37˚C. The resultant cell suspension was determined, by vitamin A staining, to contain >90% HSCs, and 95% of cells were determined be viable by trypan blue staining.
Activation of HSCs. HSCs were cultured for 3 days, then were considered static HSCs. Activated HSCs were obtained by incubation with 2 ng/ml TGF-β1. For miR transfection, HSCs were seeded (2x10 4 cells/well) into 24-well plates. At 10 days, 75 nM scramble miRNA, miR-21 inhibitor or miR-21 mimics were transfected into HSCs using Lipofectamine ® 2000. At 48 h, HSCs were washed with phosphate-buffered saline twice and lysed in 100 µl passive lysis buffer (Beyotime Institute of Biotechnology, Haimen, China) for 15 min. Whole cell lysate was collected by centrifugation at 12,000 x g for 10 min.
Construction of the luciferase reporter plasmid, transfection and dual-luciferase assay.
The pMIR-reporter vector (Applied Biosystems; Thermo Fisher Scientific, Inc.) was used to construct a plasmid containing the 3'-UTR of Smad7. Targetscan software (version, 5.1; Whitehead Institute for Biomedical Research, Cambridge, MA, USA) was used for target prediction. The fragments containing the predicted wild (5'-GCU CAC ACU UUA AUA UAA GCU A-3', the region targeted by miR-21 is marked in bold) and mutated (5'-GCU CAC ACU UUA AUA UAU CGA A-3', the mutated sequences is marked in bold) sites were directly synthesized (Shanghai GenePharma Co., Ltd.), then subcloned into a pMIR-report vector by double digestion with SacI and HindIII. HEK293 cells, obtained from the Central Laboratory, First Affiliated Hospital of Wenzhou Medical University (Wenzhou, China), were cultured in DMEM supplemented with 10% FBS and antibiotics. HEK293 cells (2.0x10 5 ) were seeded into six-well plates and cultured for 24 h, then transfected with 700 ng pMIR-reporter plasmids containing the wild or mutated 3'-UTR of Smad7 in combination with 400 nM of miR-21 mimics or scramble miRNA using Lipofectamine ® 2000. After 48 h the cells were collected and luciferase activity was measured by Dual-Luciferase Reporter Assay kit using a TD20/20 Luminometer (Turner Designs, San Jose, CA, USA). Each experiment was performed in triplicate. The results were expressed as relative Renilla luciferase activity, normalized to firefly luciferase activity.
Detection of miR-21 expression by reverse transcriptionquantitative polymerase chain reaction (RT-qPCR).
Total RNA from rat HSCs was extracted by using RNApure Total RNA kit following the manufacturer's instructions. The first-strand cDNA was synthesized by stem-loop primers and RevertAid RT Reverse Transcription kit. qPCR of miR-21 was carried out using miR-21 specific primers (Table I) and SYBR-Green real-time PCR Master Mix on an ABI Prism 7500 machine (Thermo Fisher Scientific, Inc.) following the manufacturer's protocol. The level of U6 mRNA (Table I) was used as an internal control, and relative mRNA expression was calculated from three independent experiments. Thermocycling conditions were as follows: An initial predenaturation step for 5 min at 95˚C, followed by 30 cycles of denaturation at 94˚C for 45 sec, annealing at 56˚C for 45 sec and extension at 72˚C for 10 min. The fold-change in miR-21, relative to U6, was determined by the 2 -ΔΔCq method (22) .
Detection of SMAD7, α-SMA, COLLA1, COLLA2 and GAPDH mRNA expression in HSCs using RT-qPCR. Total RNA extraction and first-strand synthesis were performed as described above. Specific primers for SMAD7, α-SMA, COLLA1, COLLA2 and GAPDH were designed using Primer Premier software (Table I ; version, 5.0; Premier Biosoft, Palo Alto, CA, USA), and synthesized by Takara Biotechnology Co., Ltd. (Dalian, China). PCR reaction conditions were optimized for each set of primers (Table I) , and carried out as described above. The threshold cycle (Ct) was determined and the fold-change in SMAD7, α-SMA, COLLA1, COLLA2 mRNA levels were calculated, relative to GAPDH, using Ct values.
Western blotting. Protein concentration was determined using the bicinchoninic acid assay protein assay kit (Biorbyt, Ltd., Cambridge, UK 
Results
TGF-β1 upregulates miR-21 expression, but inhibits Smad7
expression, in rat HSCs. TGF-β1 is a profibrogenic cytokine that induces HSCs activation (3,4) and upregulates expression of miR-21 during fibrosis (15) . In the present study, the authors first investigated the effect of exogenous TGF-β1 on miR-21 expression in rat primary HSCs. Incubation with 2 ng/ml TGF-β1 was indicated to significantly enhanced miR-21 expression, in a time-dependent manner (P<0.01 or P<0.001). The effect was greatest 7 days following addition of TGF-β1 (Fig. 1A) . However, expression of Smad7 mRNA was significantly reduced in the presence of TGF-β1 (P<0.01; Fig. 1B) , and cellular content of Smad7 protein was also significantly reduced followings incubation with TGF-β1 (P<0.01; Fig. 1C ). Fig. 2A and B). miR-21 is reported to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts by targeting dual specific phosphatase 8 (24) . miR-21 mimics were identified to significantly upregulated expression of COLLA1 and COLLA2 mRNA in activated HSCs (P<0.001), while the miR-21 inhibitor significantly suppressed their expression (P<0.01; Fig. 2C ).
miR-21 directly regulates expression of Smad7 in activated rat
HSCs. miR-21 overexpression was recently reported to contribute to TGF-β1-induced epithelial-to-mesenchymal transition (EMT) by inhibiting Smad7 (20) . Moreover, Smad7 overexpression in the liver inhibits phosphorylation of Smad2/3 and collagen I expression (9) . Thus, the authors hypothesize that Smad7 may interfere with the process by which miR-21 promotes collagen I expression in activated rat HSCs. Indeed, miR-21 mimics were observed to significantly reduce expression of Smad7 mRNA and protein in activated HSCs (P<0.01), while a miR-21 inhibitor significantly enhanced expression of Smad7 mRNA and protein (P<0.01 or P<0.001; Fig. 3A and B). These results suggested that miR-21 may regulate Smad7 expression in activated HSCs. To further investigate whether Smad7 is a direct target of miR-21, the authors cloned the wild type or mutated 3'-UTR of the Smad7 gene into a pMIR-report vector and overexpressed these plasmids in HEK293 cells. Furthermore, these cells were transfected with miR-21 mimics or scramble miRNA, and compared the Renilla and firefly luciferase activity in these cells. Firefly luciferase luminescence was quite low in these cells, and only elevated in cells transfected with the plasmid containing the wild type 3'-UTR of Smad7 and miR-21 mimics. Higher levels of firefly luciferase luminescence were detected in the cells transfected with plasmids containing the wild type 3'-UTR of Smad7 and miR-21 mimics, and thus the ratio of Renilla to firefly luciferase in this group was significantly lower than in other groups (P<0.01; Fig. 4 ). These observations indicated that miR-21 directly binds the 3'-UTR of Smad7.
Discussion miR-21 is one of the most commonly and highly upregulated miRNAs in many cancers (12), and has been reported to contribute to lung, heart, and kidney fibrosis (13, 14) . miR-21
was also recently reported to mediate ERK1 signaling and EMT by regulating SPRY2 and HNF4α expression during liver fibrosis, suggesting that miR-21 may represent a potential biomarker of hepatic cirrhosis, and that inhibition miR-21 may prove therapeutically beneficial (18) . However, the precise mechanism by which miR-21 participates in liver fibrosis remains to be determined. Liver fibrosis is characterized by activation and transdifferentiation of HSCs to myofibroblasts (1,2) . HSCs are usually quiescent in healthy liver tissue, and thus termed Primary HSCs were cultured for 3 days, then incubated with 2 ng/ml TGF-β1 for 2 days (day 5) and 7 days (day 10). Expression of miR-21 in HSCs was assessed by RT-qPCR. The level of miR-21 expression in untreated cells at day 3 was adjusted to 1, expression at day 5 and day 10 following TGF-β1 incubation was normalized to day 3. U6 expression was used as an internal control (n=8). (B) TGF-β1 alters expression of SMAD7 in activated HSCs. Total RNA was isolated from the cells incubated with 2 ng/ml TGF-β1 for 2 days, and subjected to RT-qPCR analysis. GAPDH was used as an internal control (n=8). (C) TGF-β1 alters Smad7 protein content of activated HSCs. Total protein was isolated from the cells incubated with 2 ng/ml TGF-β1 for 2 days, and subjected to western blot analysis. β-actin was used as an internal control (n=8). The level of Smad7 (B) mRNA and (C) protein in control cells was adjusted to 1, its expression after TGF-β1 incubation was normalized to control cells. Data are presented as the mean ± standard deviation. P<0.01, P<0.001 as indicated. miR, microRNA; HSC, hepatic stellate cells; TGF, transforming growth factor; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.
vitamin A-storing adipogenic cells (25) . However, upon liver injury, HSCs undergo a major phenotypic transition to become hepatic myofibroblasts. This transition is characterized by aberrant expression of α-SMA, collagen I and the secretion of TGF-β1, an important fibrogenic growth factor (25) . TGF-β has been demonstrated to promote miR-21 expression by enhancing formation of the R-Smad protein complex (15) . Consistent with previous findings, the authors observed that incubating rat primary HSCs with 2 ng/ml TGF-β1 significantly increased miR-21 expression in a time-dependent manner. Moreover, a previous study demonstrated that TGF-β accelerates HSC transformation into myofibroblasts by increasing expression of α-SMA and collagen (5). Furthermore, Liu et al (13) reported that miR-21 overexpression enhanced TGF-β1-induced transcription of Fn and α-SMA in pulmonary fibroblasts and, conversely, miR-21 knockdown attenuated TGF-β1-dependent transcription of Fn and α-SMA. In rat TGF-β1-induced HSCs, similar results were observed. miR-21 mimics significantly enhanced expression of α-SMA mRNA and protein, while a miR-21 inhibitor significantly suppressed expression of α-SMA mRNA and protein. miR-21 was reported to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts by targeting dual specific phosphatase 8 (24) . The present study verified that expression of COLLA1 and COLLA2 mRNA in activated rat HSCs was regulated by miR-21, indicating that miR-21 serves a key role in the TGF-β1-induced activation of HSCs. Upon TGF-β stimulation, Smad-7 transcription is usually induced by Smad-2/3 and Smad-4 (26), elevated Smad-7 in turn suppresses TGF-β-signaling through two HSCs were incubated with 75 nM scramble, miR-21 mimics or miR-21 inhibitor for 48 h, then total RNA was isolated to measure α-SMA mRNA levels (n=8). (B) Effect of miR-21 mimics and inhibitor on α-SMA protein content. HSCs were treated, as in Fig. 2A , and total protein was isolated to detect α-SMA content (n=8). (C) Effect of miR-21 mimics and inhibitor on expression of COLLA1 and COLLA2. The level of mRNA and protein in scramble cells was adjusted to 1, the mRNA and protein expression following incubation with miR-21 mimics and inhibitor was normalized to scramble cells (n=8). Data are presented as the mean ± standard deviation. P<0.01, P<0.001 as indicated. miR, microRNA; SMA, smooth muscle actin; COLLA, collagen type I alpha; HSCs, hepatic stellate cells. major mechanisms: (1) Inhibition of the TGF-β type I receptor (27) and (2) by interacting with Smurf2 to form an E3 ubiquitin ligase that degrades TGF-β type I receptor (8) . Smad7 overexpression was recently reported to inhibit HSC transdifferentiation and attenuate fibrosis, highlighting Smad7 as a promising target for antifibrotic treatment (9) . Interestingly, in the current study, the Smad7 mRNA and protein levels were significantly reduced in rat HSCs incubated with TGF-β1. Although this finding is not consistent with previous studies (7,26), a recent Bian et al (3) recently reported that epigenetic repression of Smad7 by DNA methylation promotes HSC activation and liver fibrosis in rats. Thus, reduced Smad7 expression likely indicates the activation of HSCs by TGF-β1. Moreover, increasing evidence suggest that in fibrosis miR-21 regulates synthesis of Smad7 protein (1, 13) . The expression of Smad7 mRNA and protein was downregulated by miR-21 mimics, but upregulated by the miR-21 inhibitor in activated rat HSCs. More importantly, the authors further verified that miR-21 mimics can specifically bind the 3'-UTR of Smad7, which is consistent with a previous report (20) . These results may help to explain how incubation with TGF-β1 reduced Smad7 expression, because the inhibitory effect of elevated miR-21 on Smad7 expression may completely suppress the inducing effect of TGF-β1 after 48 h. These data provides further evidence that miR-21 acts as a profibrogenic miRNA by inhibiting Smad-7 expression, suggesting that miR-21/Smad7 signaling may be a promising and key target for the treatment of liver fibrosis.
In the current study, the authors did not verify whether elevated expression of α-SMA, COLLA1 and COLLA2 in activated rat HSCs is caused by the repression of Smad7. However, Dooley et al (9) previously reported that Smad7-overexpressing BDL (ligation of the common bile duct) rats expressed less collagen and α-SMA expression in the liver (28), while acetaldehyde upregulated expression of COL1A2 by 3.5-fold through Smad7 in HSCs (29) . Thus, these studies provide evidence that Smad7 can directly enhance expression of α-SMA and collagen I in activated HSCs.
In conclusion, the authors demonstrated that miR-21 regulates expression of α-SMA and collagen I in rat TGF-β1-activated HSCs by inhibiting Smad7 expression. The Fig. 2A and reverse transcription-quantitative polymerase chain reaction analysis was carried out to measure SMAD7 mRNA expression (n=8). (B) Effect of miR-21 mimics and inhibitor on Smad7 protein expression. HSCs were treated as described in Fig. 2A  (n=8) . Data are presented as the mean ± standard deviation. P<0.01, P<0.001 as indicated. miR, microRNA; HSCs, hepatic stellate cells. present study provides evidence that miR-21/Smad7 signaling serves an important role in the pathogenesis of liver fibrosis.
